Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apriso for maintenance of remission in ulcerative colitis
NCT00744016Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Started Dec 2004; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00744016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744016.